Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.

Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.

Continual will increase within the ranges of the inflammatory cytokine interleukin-6 (IL-6) in serum and skeletal muscle are thought to contribute to the development of muscular dystrophy. Dystrophin/utrophin double-knockout (dKO) mice develop a extra extreme and progressive muscular dystrophy than the mdx mice, the commonest murine mannequin of Duchenne muscular dystrophy (DMD). Specifically, dKO mice…

Read More